The buying and use of business information is an investment. An investment which will pay dividends in terms of staff time saved, new opportunities identified and risks minimised. That is why the business intelligence you buy must pass a number of quality tests and be based on sound and proven research, forecasting and editorial techniques.
For 30 years Espicom has operated in the global health industry market. Our products and services rightly have earned a reputation for consistently delivering high-quality and reliable information. Here’s why.
Espicom operates on a fee or subscription basis. We do not take paid advertising or sponsorship and are free from the commercial pressures that can arise in publishers that do. Our independence is your assurance of impartiality and balance.
With over 30 years of continuous research and editorial experience in the global health industry, Espicom is one of the longest established independent business intelligence providers operating today.
Espicom produces original analysis, news and forecasts using its skilled and experienced team of more than 30 full-time in-house analysts, researchers and editorial experts. With a combined experience of over 200 years they cover key disciplines including pharmacology, biosciences, economics statistics and languages. In addition, a select group of experts are on hand in respect of specialist scientific/technology areas. We do not use freelancers or subcontractors to produce our class leading subscription and intelligence services. This gives us control and you confidence.
Second-hand information and unfounded speculation are unreliable and can’t be trusted. Espicom has built strong and enduring links with primary source information providers in over 1,200 government health departments, statistics offices and trade associations and directly monitors thousands of pharmaceutical and medical device companies. We do not use secondary source material or 3rd party databases for the services we produce.
The old model of supplying large volumes of information in generalist services or large databases has increasingly become unattractive in a health industry which is becoming more and more focussed on key sectors. Espicom’s proprietary web delivery means customers can choose precisely the aspects of those services they need. This brings clarity to your research and analysis efforts and saves buying information that will not be used. At the same time, we recognise that traditional print and pdf formats are preferred by some customers, and these are available as well. Being service driven isn’t a vague ambition. It’s about working with customers to deliver relevant information at the time of need.